Tariq Sethi

7.5k total citations · 1 hit paper
58 papers, 5.8k citations indexed

About

Tariq Sethi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Tariq Sethi has authored 58 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Tariq Sethi's work include Peptidase Inhibition and Analysis (15 papers), Galectins and Cancer Biology (14 papers) and Cell Adhesion Molecules Research (12 papers). Tariq Sethi is often cited by papers focused on Peptidase Inhibition and Analysis (15 papers), Galectins and Cancer Biology (14 papers) and Cell Adhesion Molecules Research (12 papers). Tariq Sethi collaborates with scholars based in United Kingdom, United States and Sweden. Tariq Sethi's co-authors include Alison C. MacKinnon, Neil C. Henderson, Christopher Haslett, Robert C. Rintoul, Sarah L. Farnworth, John P. Iredale, Edwin R. Chilvers, Stuart J. Forbes, Mark H. Ginsberg and Brian J. McHugh and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Tariq Sethi

58 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

1999 620 citations Tariq Sethi, Robert C. Rintoul et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tariq Sethi United Kingdom	36	2.6k	2.2k	1.5k	1.0k	560	58	5.8k
Joseph E. Italiano United States	50	2.9k 1.1×	1.6k 0.7×	1.6k 1.1×	1.6k 1.5×	876 1.6×	133	9.7k
Yoshihisa Nojima Japan	40	2.2k 0.8×	1.6k 0.7×	844 0.6×	514 0.5×	772 1.4×	231	6.1k
Jerry Ware United States	50	2.0k 0.8×	1.4k 0.7×	1.0k 0.7×	1.1k 1.0×	1.1k 1.9×	148	8.4k
Owen J. T. McCarty United States	48	1.4k 0.5×	1.3k 0.6×	978 0.7×	982 1.0×	643 1.1×	242	7.7k
G. Kenneth Haines United States	43	2.1k 0.8×	2.3k 1.1×	2.2k 1.4×	639 0.6×	683 1.2×	92	6.6k
Henri H. Versteeg Netherlands	37	1.7k 0.7×	1.1k 0.5×	872 0.6×	755 0.7×	628 1.1×	129	7.1k
Martin Sattler United States	55	4.3k 1.7×	1.2k 0.6×	2.4k 1.6×	694 0.7×	302 0.5×	151	8.6k
Curzio Rüegg Switzerland	45	3.0k 1.1×	1.8k 0.8×	2.2k 1.5×	598 0.6×	319 0.6×	132	6.4k
Lubor Borsig Switzerland	43	3.3k 1.3×	1.7k 0.8×	2.1k 1.4×	580 0.6×	472 0.8×	99	7.1k
Shelia M. Violette United States	37	2.1k 0.8×	747 0.3×	1.2k 0.8×	1.2k 1.2×	525 0.9×	71	5.2k

Countries citing papers authored by Tariq Sethi

Since Specialization

Citations

This map shows the geographic impact of Tariq Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tariq Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tariq Sethi more than expected).

Fields of papers citing papers by Tariq Sethi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tariq Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tariq Sethi. The network helps show where Tariq Sethi may publish in the future.

Co-authorship network of co-authors of Tariq Sethi

This figure shows the co-authorship network connecting the top 25 collaborators of Tariq Sethi. A scholar is included among the top collaborators of Tariq Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tariq Sethi. Tariq Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Humphries, Duncan C., Ross Mills, Brian J. McHugh, et al.. (2022). Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation. Frontiers in Pharmacology. 13. 949264–949264. 22 indexed citations

Psallidas, Ioannis, Vibeke Backer, Piotr Kuna, et al.. (2020). A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma. American Journal of Respiratory and Critical Care Medicine. 203(3). 296–306. 17 indexed citations

Vuong, Lynda, Claire Rooney, Brian J. McHugh, et al.. (2019). An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade. Cancer Research. 79(7). 1480–1492. 104 indexed citations

Johnson, Jo-Anne, Peter McErlean, Julien Bauer, et al.. (2017). SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 195(11). 1494–1508. 27 indexed citations

Delaine, Tamara, P.M. Collins, Alison C. MacKinnon, et al.. (2016). Galectin‐3‐Binding Glycomimetics that Strongly Reduce Bleomycin‐Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition. ChemBioChem. 17(18). 1759–1770. 151 indexed citations

Cane, Paul, et al.. (2015). Microdroplet Digital PCR: Detection and Quantitation of Biomarkers in Archived Tissue and Serial Plasma Samples in Patients with Lung Cancer. Journal of Thoracic Oncology. 10(1). 212–217. 11 indexed citations

MacKinnon, Alison C., Nicolaos Avlonitis, Mark Bradley, et al.. (2014). CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist. Cancer Research. 74(5). 1554–1565. 165 indexed citations

Wang, Wei, Philip S. Hodkinson, Melanie Mackean, et al.. (2013). Histologic Assessment of Tumor-Associated CD45+ Cell Numbers Is an Independent Predictor of Prognosis in Small Cell Lung Cancer. CHEST Journal. 143(1). 146–151. 49 indexed citations

Wang, Wei, Philip S. Hodkinson, Alison C. MacKinnon, et al.. (2012). Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3⁺ cells in tumour infiltrate. International Journal of Cancer. 131(6). E928–37. 80 indexed citations

10.

Gibbons, Michael, Alison C. MacKinnon, Prakash Ramachandran, et al.. (2011). Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(5). 569–581. 363 indexed citations

11.

MacKinnon, Alison C., Michael Gibbons, Sarah L. Farnworth, et al.. (2011). Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3. American Journal of Respiratory and Critical Care Medicine. 185(5). 537–546. 397 indexed citations

12.

Henderson, Neil C. & Tariq Sethi. (2009). The regulation of inflammation by galectin‐3. Immunological Reviews. 230(1). 160–171. 423 indexed citations

13.

Hodkinson, Philip S., Alison C. MacKinnon, & Tariq Sethi. (2008). Targeting Growth Factors in Lung Cancer. CHEST Journal. 133(5). 1209–1216. 35 indexed citations

14.

Henderson, Neil C., Alison C. MacKinnon, Sarah L. Farnworth, et al.. (2006). Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proceedings of the National Academy of Sciences. 103(13). 5060–5065. 492 indexed citations

15.

Henderson, Neil C., Alison C. MacKinnon, Kenneth J. Simpson, et al.. (2004). CD98hc (SLC3A2) Interaction with β1 Integrins Is Required for Transformation. Journal of Biological Chemistry. 279(52). 54731–54741. 68 indexed citations

16.

MacKinnon, Alison C., et al.. (2002). Sphingosine Kinase: A Point of Convergence in the Action of Diverse Neutrophil Priming Agents. The Journal of Immunology. 169(11). 6394–6400. 61 indexed citations

17.

Newsome, Philip N., Karen J. Humphreys, John Tsiaoussis, et al.. (2001). Serum from patients with acute liver failure decreases cellular adhesion prior to inducing apoptotic cell death; Important implications for hepatocyte transplantation.. Hepatology. 34(4). 1 indexed citations

18.

Rintoul, Robert C. & Tariq Sethi. (2001). The role of extracellular matrix in small-cell lung cancer. The Lancet Oncology. 2(7). 437–442. 62 indexed citations

19.

Sethi, Tariq, Mark H. Ginsberg, Julian Downward, & Paul E. Hughes. (1999). The Small GTP-binding Protein R-Ras Can Influence Integrin Activation by Antagonizing a Ras/Raf-initiated Integrin Suppression Pathway. Molecular Biology of the Cell. 10(6). 1799–1809. 82 indexed citations

20.

Fenczik, Csilla A., Tariq Sethi, Joe W. Ramos, Paul E. Hughes, & Mark H. Ginsberg. (1997). Complementation of dominant suppression implicates CD98 in integrin activation. Nature. 390(6655). 81–85. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact